Nitto Avecia
Michelle LeBoeuf is an experienced manufacturing compliance specialist currently employed at Nitto Denko Avecia Inc. since December 2019. Prior to this role, Michelle served as a manufacturing specialist in biomanufacturing at GE Healthcare, where responsibilities included real-time review of cGMP documentation and deviation investigations. At Alexion Pharmaceuticals, Michelle held several positions, including team lead for purification operations and manufacturing specialist focusing on deviation management and root cause analysis. Michelle's earlier experience includes roles at Lonza as a deviation investigator and manufacturing supervisor, as well as a manufacturing technical trainer at Antigenics and various roles at Organogenesis and AstraZeneca. Extensive expertise in cGMP compliance, team leadership, and training in biopharmaceutical manufacturing processes has been demonstrated throughout Michelle's career.
Nitto Avecia
1 followers
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.